CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

WOC Pharma and Healthcare Fund-Reg(G)

very highequitypharma & health care
14.03 0.04(0.27%) NAV as on 25 Nov 2025
-0.66 % 1 M
7.01 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.38

As on 31 Oct, 2025
age-icon Age :

1 yrs 9 m

Since 06 02 ,2024
exit_load Exit Load :

1%

aum AUM :

480.08 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

9.01

Min_Investment Min. Investment :

SIP 100 & Lumpsum 500

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2025
Debt 3.68 %
Others 5.43 %
Equity 90.89 %

TOP HOLDINGS

Sun Pharmaceutical Industries...7.82 %
Divi's Laboratories Ltd.6.87 %
JB Chemicals & Pharmaceuticals...6.48 %
Fortis Healthcare Ltd.6.32 %
Laurus Labs Ltd.4.68 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs64.90
Hospital & Healthcare Services22.88
Plastic Products1.19
Medical Equipment/Supplies/Accessories1.07
Chemicals0.85
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-2025
NAV in Rs (as on 31-Mar-2025)9.9612.74
Net Assets(Rs Crores) (as on 31-Mar-2025) 108.61 303.62
Scheme Returns(%)(Absolute)-0.4426.85
B'mark Returns(%)(Absolute)NANA
Category Rank85/902/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

WOC Pharma and Healthcare Fund-Reg(G)Very HighEquity14.030.04(0.27%)NAV As on 25 Nov, 202506-Feb-2024Inception Date480.08AUM In Cr.7.01%1YNA%3YNA%5Y20.67%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity287.600.59(0.21%)NAV As on 25 Nov, 202501-Aug-2005Inception Date1,124.88AUM In Cr.0.82%1Y23.63%3Y17.06%5Y17.96%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.680.08(0.28%)NAV As on 25 Nov, 202528-Dec-2015Inception Date1,324.90AUM In Cr.1.57%1Y21.76%3Y17.27%5Y11.97%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.